Explore how Dentsply's (XRAY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.
DENTSPLY SIRONA Inc. ( XRAY ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Wade Moody Daniel Scavilla - President, CEO & Director Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division David Saxon - Needham & Company, LLC, Research Division Jordan Bernstein - Stifel, Nicolaus & Company, Incorporated, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Ahmed Muhammad Rahat - Leerink Partners LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Allen Lutz - BofA Securities, Research Division Brandon Vazquez - William Blair & Company L.L.C.
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Daniel T. Scavilla CEO | XWBO Exchange | US24906P1093 ISIN |
| US Country | 14,000 Employees | 26 Sep 2025 Last Dividend | 18 Jul 2006 Last Split | 12 Aug 1987 IPO Date |
DENTSPLY SIRONA Inc., a pioneering company in the dental industry, operates globally to manufacture and distribute a wide array of dental products and technologies. The company's operation is divided into four main segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. Originally known as DENTSPLY International Inc., it underwent a name change to DENTSPLY SIRONA Inc. in February 2016, reflecting the company's expansion and integration of various dental technologies. Founded in 1877 with its headquarters located in Charlotte, North Carolina, DENTSPLY SIRONA serves the professional dental market and the consumable medical device market through third-party distributors, cementing its status as a key player in dental care innovation.